<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03924778</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-300003207</org_study_id>
    <nct_id>NCT03924778</nct_id>
  </id_info>
  <brief_title>Modifying Diet to Improve Gut Microbiome</brief_title>
  <official_title>Modifying Diet and the Gut Microbiota to Reduce Obesity and Health Disparities</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will conduct a 2-arm randomized controlled pilot, feasibility feeding study
      in which 28 participants will be randomized to receive either a calorie-restricted Dietary
      Approaches to Stop Hypertension (DASH) diet or a calorie-restricted standard American diet
      provided by the study for 4 weeks. Participants will be non-Hispanic black or white,
      generally healthy females (14 black, 14 white). The investigators will collect fecal samples
      at multiple time points before, during, and after the dietary intervention to analyze for
      changes in the gut microbiota and functional-level metabolic products. This work will be led
      by an interdisciplinary team including expertise in bio-behavioral science, microbiology,
      nutrition science, bioinformatics, and biostatistics all with cross-cutting expertise in
      health disparities, prevention research, nutrition, the gut microbiota, inflammation and
      other biomarkers. The rationale for the proposed research is that once the interactions
      between race, diet, and the gut microbiota are more fully understood, targeted diet
      modifications may provide new and innovative approaches for the prevention and treatment of
      obesity and obesity-related diseases.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 5, 2019</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Weight Change of Participants</measure>
    <time_frame>Baseline to day 28</time_frame>
    <description>Weight change as measured by a scale in kilograms at multiple time points will be calculated and averaged.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Weight Change of Participants</measure>
    <time_frame>Day 28 to Day 42</time_frame>
    <description>Weight change as measured by a scale in kilograms at multiple time points will be calculated and averaged.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Weight Change of Participants</measure>
    <time_frame>Baseline to day 42</time_frame>
    <description>Weight change as measured by a scale in kilograms at multiple time points will be calculated and averaged.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diet-specific changes in secondary bile acid</measure>
    <time_frame>Baseline to day 28</time_frame>
    <description>The investigators will calculate changes in cholic acid in milligrams.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diet-specific changes in secondary bile acid</measure>
    <time_frame>day 28 to day 42</time_frame>
    <description>The investigators will calculate changes in cholic acid in milligrams.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diet-specific changes in secondary bile acid</measure>
    <time_frame>baseline to day 42</time_frame>
    <description>The investigators will calculate changes in cholic acid in milligrams.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diet-specific changes in inflammatory marker</measure>
    <time_frame>baseline to day 28</time_frame>
    <description>The investigators will calculate changes in c-reactive protein in mg/L.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diet-specific changes in inflammatory marker</measure>
    <time_frame>day 28 to day 42</time_frame>
    <description>The investigators will calculate changes in c-reactive protein in mg/L.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diet-specific changes in inflammatory marker</measure>
    <time_frame>baseline to day 42</time_frame>
    <description>The investigators will calculate changes in c-reactive protein in mg/L.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diet-specific changes in short chain fatty acids</measure>
    <time_frame>baseline to day 28</time_frame>
    <description>The investigators will calculate changes in acetic acid in mmol/L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diet-specific changes in short chain fatty acids</measure>
    <time_frame>day 28 to day 42</time_frame>
    <description>The investigators will calculate changes in acetic acid in mmol/L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diet-specific changes in short chain fatty acids</measure>
    <time_frame>baseline to day 42</time_frame>
    <description>The investigators will calculate changes in acetic acid in mmol/L</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">28</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>DASH diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>calorie-restricted DASH diet (25% fat; 57% carbohydrate; 18% protein; 34 g fiber</description>
  </arm_group>
  <arm_group>
    <arm_group_label>standard American diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>calorie-restricted standard American diet (35% fat; 51% carbohydrate; %15 protein; 14 g fiber</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>DASH diet</intervention_name>
    <description>brief description</description>
    <arm_group_label>DASH diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>standard American diet</intervention_name>
    <description>describe</description>
    <arm_group_label>standard American diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  female

          -  non-Hispanic, black or white

          -  age 19-65 years

          -  BMI &gt;= 30 kg/m^2

          -  able to visit Bionutrition Unit daily

        Exclusion Criteria:

          -  gastrointestinal (GI) conditions i.e., irritable bowel, diverticulitis, peptic ulcers,
             Crohn's, GI cancers, and adenatomous polyps

          -  antibiotic or probiotic use in the previous 90 days

          -  tobacco use

          -  heavy alcohol consumption

          -  major medical conditions (e.g., renal disease, diabetes, cancer)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tiffany L Carson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tiffany L Carson, PhD</last_name>
    <phone>205-934-1443</phone>
    <email>tiffanycarson@uabmc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tiffany Carson, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Tiffany Carson, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>March 25, 2019</study_first_submitted>
  <study_first_submitted_qc>April 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 23, 2019</study_first_posted>
  <last_update_submitted>June 23, 2020</last_update_submitted>
  <last_update_submitted_qc>June 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Tiffany Carson</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

